₹419.00▲₹7.35(+1.75%)
EOD close · 3 Jul 2026
mid rallyneutral +14
Above 50- and 200-day MAs with +20.9% over 3 months — established uptrend.
52W low ₹331.0052W high ₹440.30
Now at 81% of its 52-week range
Long-term returns
1Y
+13.8%
3Y
+61.8%
5Y
+4.5%
10Y
+245.9%
Phase indicator
mid rally-4.8% from 52w high
Above 50- and 200-day MAs with +20.9% over 3 months — established uptrend.
1M
+3.4%
3M
+20.9%
1Y
+13.8%
Delivery conviction
neutralscore +14
Delivery vs 20-day avg1.12x
Lifetime story
Biocon is up 2803.7% from its lifetime low of ₹14.43 on 28 Nov 2008. ₹10,000 invested then would be worth ₹2,90,367 today (21.1% CAGR over 17.6 years). Lifetime high of ₹567.95 was set on 5 Apr 2017 (currently -26.2% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
3643% premium to industry(Industry P/E 49.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 1853.26 | 179.85 |
| P/Bsubs material | 2.57 | 2.05 |
| Price / Cash flowsubs material | 398.36 | 29.66 |
| Dividend yield | 0.12% | 0.12% |
| Book value / sharesubs material | 166.19 ₹ | 208.85 ₹ |
| EPS (TTM)subs material | 0.23 ₹ | 2.37 ₹ |
Market cap
₹69.5K Cr
52W high
₹440.30
26 May 2026
52W low
₹331.00
11 Aug 2025
Returns ladder
1W
+2.5%
1M
+3.4%
3M
+20.9%
6M
+8.4%
YTD
+8.2%
1Y
+13.8%
3Y
+61.8%
5Y
+4.5%
10Y
+245.9%
Since listing
+956.1%